[{"id":"363c4301-48c3-4930-8568-cf045174c019","acronym":"ARETHA","url":"https://clinicaltrials.gov/study/NCT05570253","created_at":"2022-10-06T13:55:55.168Z","updated_at":"2024-07-02T16:35:00.755Z","phase":"Phase 2","brief_title":"A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer","source_id_and_acronym":"NCT05570253 - ARETHA","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" HER-2 • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Halaven (eribulin mesylate) • evexomostat (SDX-7320)"],"overall_status":"Recruiting","enrollment":" Enrollment 55","initiation":"Initiation: 10/03/2022","start_date":" 10/03/2022","primary_txt":" Primary completion: 10/01/2027","primary_completion_date":" 10/01/2027","study_txt":" Completion: 10/01/2027","study_completion_date":" 10/01/2027","last_update_posted":"2024-05-27"},{"id":"846b7653-3cb1-438a-96c1-7360840819e9","acronym":"Amelia-1","url":"https://clinicaltrials.gov/study/NCT05455619","created_at":"2022-07-13T12:56:21.512Z","updated_at":"2024-07-02T16:35:02.003Z","phase":"Phase 1/2","brief_title":"Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Women With a PI3K Alteration and HR+/Her2- Breast Cancer","source_id_and_acronym":"NCT05455619 - Amelia-1","lead_sponsor":"SynDevRx, Inc.","biomarkers":" HER-2 • PIK3CA","pipe":" | ","alterations":" HER-2 negative • PIK3CA mutation","tags":["HER-2 • PIK3CA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PIK3CA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Piqray (alpelisib) • fulvestrant • evexomostat (SDX-7320)"],"overall_status":"Recruiting","enrollment":" Enrollment 52","initiation":"Initiation: 08/26/2022","start_date":" 08/26/2022","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-05-22"}]